Literature DB >> 8821736

The effects of selective A1 and A2a adenosine receptor antagonists on cerebral ischemic injury in the gerbil.

J W Phillis1.   

Abstract

Cerebral ischemia of 5 min duration was induced in unanesthetized Mongolian gerbils by bilateral occlusion of the carotid arteries. The extent of ischemic injury was assessed behaviorally by measuring the increases in locomotor activity following ischemia and by a histopathological assessment of the extent of CA1 hippocampal pyramidal cell injury and loss 5 days after ischemia. The A2a adenosine receptor selective antagonists 8-(3-chlorostyryl) caffeine (CSC; 0.1 mg/kg i.p.) and 4-amino-1-phenyl[1,2,4]-triazolo[4,3-a] quinoxaline (CP 66,713; 0.1 mg/kg i.p.) reduced the extent of ischemia-induced injury. An A1 selective receptor antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX; 1.0 mg/kg i.p.), enhanced ischemia-evoked injury. These results suggest that adenosine A2a receptor antagonists may be useful for the prevention of cerebral injuries resulting from stroke or cardiac arrest.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8821736     DOI: 10.1016/0006-8993(95)01153-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  40 in total

1.  A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice.

Authors:  J F Chen; Z Huang; J Ma; J Zhu; R Moratalla; D Standaert; M A Moskowitz; J S Fink; M A Schwarzschild
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

2.  Activation of Trk neurotrophin receptors in the absence of neurotrophins.

Authors:  F S Lee; M V Chao
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

Review 3.  Beneficial and detrimental role of adenosine signaling in diseases and therapy.

Authors:  Hong Liu; Yang Xia
Journal:  J Appl Physiol (1985)       Date:  2015-08-27

4.  Pre-conditioning protection in the brain.

Authors:  T W Stone
Journal:  Br J Pharmacol       Date:  2003-08-11       Impact factor: 8.739

Review 5.  Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.

Authors:  Marie Therese Armentero; Annalisa Pinna; Sergi Ferré; José Luis Lanciego; Christa E Müller; Rafael Franco
Journal:  Pharmacol Ther       Date:  2011-07-23       Impact factor: 12.310

6.  Continuous adenosine A2A receptor antagonism after focal cerebral ischemia in spontaneously hypertensive rats.

Authors:  Ulrike Fronz; Alexander Deten; Frank Baumann; Alexander Kranz; Sarah Weidlich; Wolfgang Härtig; Karen Nieber; Johannes Boltze; Daniel-Christoph Wagner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-10-30       Impact factor: 3.000

7.  Hypoxia/reoxygenation impairs memory formation via adenosine-dependent activation of caspase 1.

Authors:  Gabriel S Chiu; Diptaman Chatterjee; Patrick T Darmody; John P Walsh; Daryl D Meling; Rodney W Johnson; Gregory G Freund
Journal:  J Neurosci       Date:  2012-10-03       Impact factor: 6.167

Review 8.  Tryptophan, adenosine, neurodegeneration and neuroprotection.

Authors:  T W Stone; C M Forrest; G M Mackay; N Stoy; L G Darlington
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

9.  Estrogen-dependent hypersensitivity to diabetes-evoked cardiac autonomic dysregulation: Role of hypothalamic neuroinflammation.

Authors:  Mohamed A Fouda; Korin E Leffler; Abdel A Abdel-Rahman
Journal:  Life Sci       Date:  2020-03-31       Impact factor: 5.037

Review 10.  Regulation of adenosine levels during cerebral ischemia.

Authors:  Stephanie Chu; Wei Xiong; Dali Zhang; Hanifi Soylu; Chao Sun; Benedict C Albensi; Fiona E Parkinson
Journal:  Acta Pharmacol Sin       Date:  2012-10-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.